Is vitamin E a safe prophylaxis for preeclampsia?

被引:25
作者
Banerjee, S [1 ]
Chambers, AE [1 ]
Campbell, S [1 ]
机构
[1] Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr Fetal Med, London SE5 9RS, England
关键词
vitamin E; preeclampsia; Th1/Th2; switch; atopic diseases;
D O I
10.1016/j.ajog.2005.11.034
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The prophylactic use of vitamins E and C for the prevention of preeclampsia is currently being evaluated in multiple clinical trials in Canada, Mexico, the United Kingdom, the United States, and other developing countries. In addition to its antioxidant capacity, exogenous vitamin E may prevent an immunologic switch (Th1 to Th2) that is vital for early-to late transition in normal pregnancies. Moreover, vitamin E could be a potential interferon-gamma (IFN-gamma) mimic facilitating persistent proinflammatory reactions at the fetal-maternal interface. These untoward effects of dietary intake of vitamin E may be more pronounced in those treated cases that fail to develop preeclampsia. A critical test of this hypothesis Would be to establish whether, under variable O-2 tension, vitamin E is capable of affecting cytokine signaling in placental trophoblasts and maternal immune effector cells, both in early and late human pregnancies. (c) 2006 Mosby, Inc. All rights reserved.
引用
收藏
页码:1228 / 1233
页数:6
相关论文
共 56 条
[1]   Vitamin E-enhanced IL-2 production in old mice: Naive but not memory T cells show increased cell division cycling and IL-2-producing capacity [J].
Adolfsson, O ;
Huber, BT ;
Meydani, SN .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :3809-3817
[2]   Reactive oxygen generated by Nox1 triggers the angiogenic switch [J].
Arbiser, JL ;
Petros, J ;
Klafter, R ;
Govindajaran, B ;
McLaughlin, ER ;
Brown, LF ;
Cohen, C ;
Moses, M ;
Kilroy, S ;
Arnold, RS ;
Lambeth, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :715-720
[3]   Regulation of gene expression by α-tocopherol [J].
Azzi, A ;
Gysin, R ;
Kempná, R ;
Munteanu, A ;
Villacorta, L ;
Visarius, T ;
Zingg, JM .
BIOLOGICAL CHEMISTRY, 2004, 385 (07) :585-591
[4]  
Babior B M, 1995, Curr Opin Hematol, V2, P55
[5]  
BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842
[6]   Placental expression of interferon-γ (IFN-γ) and its receptor IFN-γR2 fail to switch from early hypoxic to late normotensive development in preeclampsia [J].
Banerjee, S ;
Smallwood, A ;
Moorhead, J ;
Chambers, AE ;
Papageorghiou, A ;
Campbell, S ;
Nicolaides, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :944-952
[7]   Placental morphogenesis in pregnancies with Down's syndrome might provide a clue to pre-eclampsia [J].
Banerjee, S ;
Smallwood, A ;
Nargund, G ;
Campbell, S .
PLACENTA, 2002, 23 (2-3) :172-174
[8]   Vitamin C and E supplementation in women at high risk for preeclampsia: A double-blind, placebo-controlled trial [J].
Beazley, D ;
Ahokas, R ;
Livingston, J ;
Griggs, M ;
Sibai, BM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (02) :520-521
[9]   NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells [J].
Brar, SS ;
Corbin, Z ;
Kennedy, TP ;
Hemendinger, R ;
Thornton, L ;
Bommarius, B ;
Arnold, RS ;
Whorton, AR ;
Sturrock, AB ;
Huecksteadt, TP ;
Quinn, MT ;
Krenitsky, K ;
Ardie, KG ;
Lambeth, JD ;
Hoidal, JR .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (02) :C353-C369
[10]   Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial [J].
Chappell, LC ;
Seed, PT ;
Briley, AL ;
Kelly, FJ ;
Lee, R ;
Hunt, BJ ;
Parmar, K ;
Bewley, SJ ;
Shennan, AH ;
Steer, PJ ;
Poston, L .
LANCET, 1999, 354 (9181) :810-816